Scientists from the University of Southampton and Synairgen, a respiratory drug development company spun out from the University, can announce positive data from its Phase II clinical trial, into the effectiveness of the drug SNG001 (inhaled interferon beta) for asthma patients.

Researchers from the University of Southampton have contributed to a major international United Nation's (UN) report into the current status of the world's land and water resources for food and agriculture.

SOUTHAMPTON, Pa., Dec.

SOUTHAMPTON, Pa., Dec.

SOUTHAMPTON, Pa., Dec.